MedTrace Logo

Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder

NCT01483339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2017-10-06

No results posted yet for this study

Summary

Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Conditions

  • Obsessive-Compulsive Disorder

Interventions

BEHAVIORAL

Metacognitive Therapy

Metacognitive Therapy for OCD according to Wells (1997)

BEHAVIORAL

Exposure and Response Prevention

Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)

Sponsors & Collaborators

  • Psychotherapie-Ambulanz Marburg e.V.

    collaborator OTHER

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Cornelia Exner, Prof. Dr. · University of Leipzig

  • Winfried Rief, Prof. Dr. · Philipps University Marburg, Department of Clinical Psychology and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2017-07-31
Completion
2017-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01483339 on ClinicalTrials.gov